These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1978306)

  • 1. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.
    Roy SD; Flynn GL
    Pharm Res; 1990 Aug; 7(8):842-7. PubMed ID: 1978306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin.
    Roy SD; Hou SY; Witham SL; Flynn GL
    J Pharm Sci; 1994 Dec; 83(12):1723-8. PubMed ID: 7891301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin.
    Roy SD; Flynn GL
    Pharm Res; 1989 Oct; 6(10):825-32. PubMed ID: 2575255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin.
    Prodduturi S; Sadrieh N; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
    J Pharm Sci; 2010 May; 99(5):2357-66. PubMed ID: 19967778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal penetration of fentanyl: inter- and intraindividual variations.
    Larsen RH; Nielsen F; Sørensen JA; Nielsen JB
    Pharmacol Toxicol; 2003 Nov; 93(5):244-8. PubMed ID: 14629737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo iontophoresis of fentanyl and sufentanil in rats: pharmacokinetics and acute antinociceptive effects.
    Thysman S; Préat V
    Anesth Analg; 1993 Jul; 77(1):61-6. PubMed ID: 8317748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal absorption of fentanyl and sufentanil in man.
    Sebel PS; Barrett CW; Kirk CJ; Heykants J
    Eur J Clin Pharmacol; 1987; 32(5):529-31. PubMed ID: 2957211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems.
    Shin SH; Srivilai J; Ibrahim SA; Strasinger C; Hammell DC; Hassan HE; Stinchcomb AL
    AAPS PharmSciTech; 2018 Oct; 19(7):2778-2786. PubMed ID: 30084070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation issues associated with transdermal fentanyl delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors.
    Vanbever R; LeBoulengé E; Préat V
    Pharm Res; 1996 Apr; 13(4):559-65. PubMed ID: 8710746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin.
    Boucaud A; Machet L; Arbeille B; Machet MC; Sournac M; Mavon A; Patat F; Vaillant L
    Int J Pharm; 2001 Oct; 228(1-2):69-77. PubMed ID: 11576769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
    Scholz J; Steinfath M; Schulz M
    Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on transdermal permeation of butorphanol.
    Svozil M; Dolezal P; Hrabálek A; Mericka P
    Drug Dev Ind Pharm; 2007 May; 33(5):559-67. PubMed ID: 17520448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transdermal delivery of fentanyl.
    Lane ME
    Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.
    Gorukanti SR; Li L; Kim KH
    Int J Pharm; 1999 Dec; 192(2):159-72. PubMed ID: 10567747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.